Endoscopic retrograde cholangiopancreatography after Billroth-Ⅱ gastrectomy and its safety
10.3969/j.issn.1001-5256.2016.06.027
- VernacularTitle:Billroth-Ⅱ式胃大部切除术后行经内镜逆行胰胆管造影的安全性分析
- Author:
Ting LEI
1
;
Zhanguo NIE
;
Heman RE
Author Information
1. The Center of Digestive Disease, Urumqi General Hospital of Lanzhou Military Command of PLA, Urumqi 830000, China
- Publication Type:Research Article
- Keywords:
cholangiopancreatography, endoscopic retrograde;
gastroenterostomy
- From:
Journal of Clinical Hepatology
2016;32(6):1152-1154
- CountryChina
- Language:Chinese
-
Abstract:
ObjectiveTo investigate the safety of endoscopic retrograde cholangiopancreatography (ERCP) after Billroth-Ⅱ gastrectomy. MethodsA total of 43 patients who were admitted to our hospital and underwent Billroth-Ⅱ gastrectomy from June 2012 to June 2015 were enrolled and underwent ERCP. ResultsOf all 43 patients undergoing ERCP, 39 (90.7%) received successful intubation, 2 (4.7%) received failed intubation, and 2 (47%) experienced the complication of digestive tract perforation. Among the 39 patients who underwent ERCP, 31 (79.5%) were diagnosed with common bile duct stones (3 underwent sphincterotomy and 28 underwent endoscopic papillary balloon dilation to remove stones), 6 (15.4%) were diagnosed with benign stenosis at the end of bile duct (4 underwent papillary balloon dilation alone and 2 underwent biliary plastic stent implantation), and 1 patient each (2.6%) was diagnosed with ampullary tumor and hepatic portal metastasis of gastric cancer and received implantation of metal and plastic stents, respectively. One patient (26%) experienced acute pancreatitis after surgery. ConclusionERCP is safe and effective in patients after Billroth-Ⅱ gastrectomy and holds promise for clinical application.
